Study Comparing iNPWT Dressing and Devices Affect on Bioburden Levels and Skin Condition After Seven Days
NCT ID: NCT05559697
Last Updated: 2024-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2024-02-26
2024-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds
NCT06306716
Negative Pressure Wound Therapy: Are All Systems Alike?
NCT00590369
Negative Pressure Wound Therapy in Post-Operative Incision Management
NCT02682316
Incisional Negative Pressure Wound Therapy in Patients Undergoing Spine Surgery
NCT03820219
A Open Study to Evaluate the Performance of Dressing on Subject With High Risk of Skin Breakdown
NCT01354899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prospera Flex Incisional NPWT System
Sponsor incisional dressing connected to sponsor disposable negative pressure device placed on knee for seven days.
Sponsor incisional negative pressure wound therapy device and dressing
A sponsor incisional dressing placed on the knee and connected to a sponsor disposable negative pressure therapy device
Prevena Incisional NPWT System
Market leader incisional NPWT system (includes the device and dressing) placed on opposite knee for seven days.
Standard of Care incisional negative pressure wound therapy system
The control incisional negative pressure wound therapy system represents the standard of care system and market leader. It consists of a disposable negative pressure therapy device and incisional dressing.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sponsor incisional negative pressure wound therapy device and dressing
A sponsor incisional dressing placed on the knee and connected to a sponsor disposable negative pressure therapy device
Standard of Care incisional negative pressure wound therapy system
The control incisional negative pressure wound therapy system represents the standard of care system and market leader. It consists of a disposable negative pressure therapy device and incisional dressing.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. Male or female, aged 40 to 80 years of age
4. In good general health as evidenced by medical history
5. Healthy skin located across both knees at the dressing site location
6. No history of chronic knee pain
7. For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study
8. Agreement to adhere to Lifestyle limitations throughout study duration
9. Ability to understand and write in English
Exclusion Criteria
2. Known allergic reactions to components of the Prevena Dressing, DeRoyal Incisional dressing, Hibiclens or a history of skin irritation allergic reaction to chlorohexidine, isopropyl alcohol, chlorohexidine gluconate, or silver.
3. History of skin irritation, skin sensitivity or skin disease including psoriasis, eczema, atopic dermatitis, and skin cancer.
4. Pregnant or lactating female
Lifestyle Limitations during the Study:
During this study, participants are asked to adhere to following lifestyle limitations:
* Abstain from strenuous exercise activity such as running, playing contact sports, biking, and yard work. Participants may walk at a slow pace.
* To keep both dressings shielded from sunlight and fluorescent light (e.g. wear pants or cover with elastic bandage)
* To protect dressing and not expose to high moisture/water submersion environment.
* Limit showering to once per day
* To keep the NPWT devices on and connected to dressing at all times except when showering and changing clothes
40 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lincoln Memorial University
OTHER
DeRoyal Industries, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Principal Investigator
Role: PRINCIPAL_INVESTIGATOR
Lincoln Memorial University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lincoln Memorial University; Cedar Bluff Campus
Knoxville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Guidance Document defining Skin irritation and sensitization scale used as primary outcome
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1139
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.